tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Immutep receives FDA feedback on clinical development of eftilagimod alfa
PremiumThe FlyImmutep receives FDA feedback on clinical development of eftilagimod alfa
2M ago
Immutep Reports Significant Progress in Cancer and Autoimmune Trials
Premium
Company Announcements
Immutep Reports Significant Progress in Cancer and Autoimmune Trials
2M ago
Immutep reports Q4 cash receipts from customers A$6,000
Premium
The Fly
Immutep reports Q4 cash receipts from customers A$6,000
2M ago
Immutep’s Promising Phase 1 INSIGHT-003 Results Drive Buy Rating
PremiumRatingsImmutep’s Promising Phase 1 INSIGHT-003 Results Drive Buy Rating
4M ago
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
Premium
Company Announcements
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
4M ago
Immutep announces response rates from INSIGHT-003 trial
Premium
The Fly
Immutep announces response rates from INSIGHT-003 trial
5M ago
Immutep Achieves Key Milestones in Cancer Trials with Strong Financial Backing
PremiumCompany AnnouncementsImmutep Achieves Key Milestones in Cancer Trials with Strong Financial Backing
5M ago
Immutep reports Q3 cash receipts from customers A$12,000
Premium
The Fly
Immutep reports Q3 cash receipts from customers A$12,000
5M ago
Immutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
Premium
Ratings
Immutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100